نتایج جستجو برای: 5 fluorouracil colon cancer
تعداد نتایج: 2083830 فیلتر نتایج به سال:
PURPOSE Metastasis and drug resistance are the major limitations in the survival and management of patients with cancer. This study aimed to identify the mechanisms underlying HT29 colon cancer cell chemoresistance acquired after sequential exposure to 5-fluorouracil (5FU), a classical anticancer drug for treatment of epithelial solid tumors. We examined its clinical relevance in a cohort of pa...
In this issue of the Journal, Labianca et al. (1) report the results of a randomized trial comparing intraportal chemotherapy, systemic chemotherapy, or the combination of both regimens as adjuvant therapy for patients with Dukes’ stage B or C colon carcinoma. 5-Fluorouracil at a dosage of 500 mg/m of body surface area with 5000 IU of heparin was given through the portal vein for 7 days, starti...
Currently, there is no marker in use in the clinical management of colon cancer to predict which patients will respond efficiently to 5-fluorouracil (5-FU), a common component of all cytotoxic therapies. Our aim was to develop and validate a multigene signature associated with clinical outcome from 5-FU therapy and to determine if it could be used to identify patients who might respond better t...
Malignant tumors are the leading cause of death in Taiwan; among these, colon cancer ranks third as a cause of cancer-related death. Sann-Joong-Kuey-Jian-Tang (SJKJT), a traditional Chinese medicinal prescription, has been used to treat lymph node diseases and infectious lesions, and exhibits cytotoxic activity in many cancer cell lines. Our previous studies demonstrated that SJKJT inhibits the...
Our previous work demonstrates that DHX32 is upregulated in colorectal cancer (CRC) compared to its adjacent normal tissues. However, how overexpressed DHX32 contributes to CRC remains largely unknown. In this study, we reported that DHX32 was overexpressed in human colon cancer cells. Overexpressed DHX32 promoted SW480 cancer cells proliferation, migration, and invasion, as well as decreased t...
background and aims: among all cancers, colon cancer is common and deadly, yet preventable. the estimated worldwide incidence of colon cancer is more than one million new cases per year. this study was done to identify the epidemiological features and risk factors of colon cancer in different regions of birjand. methods: this retrospective, descriptive analytical study of patients with colon ca...
Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.
As one of the most common malignancies, colon cancer is initiated by abnormal activation of the Wnt/β-catenin pathway. Although the treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. We have found that bisbenzylisoquinoline alkaloid tetrandrine (TET) exhibits anticancer activity. TET is used as a calcium c...
This work aimed to develop a new therapeutic approach to increase the efficacy of 5-fluorouracil (5-FU) in the treatment of advanced or recurrent colon cancer. 5-FU-loaded biodegradable poly(ε-caprolactone) nanoparticles (PCL NPs) were combined with the cytotoxic suicide gene E (combined therapy). The SW480 human cancer cell line was used to assay the combined therapeutic strategy. This cell li...
Introduction: Colon carcinoma is one of the most common form of cancer that affects the health and lives of people. 5-Fluorouracil (5-Fu) has become useful as synergistically therapy with other antitumor agents in a colon cancer therapy. Short half-life, wide distribution and different side effects of 5-Fu limit its medical applicability. In this study, we have investigated the...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید